News

Mark Cuban’s Cost Plus to develop US-made ibogaine in HHS push

By Ella Ruder 1 min read

Mark Cuban Cost Plus Drug Co. will lead research teams laying the groundwork for a domestically manufactured ibogaine product, part of an HHS effort to develop the psychedelic as a potential treatment for post-traumatic stress disorder and other serious mental illnesses, including among veterans. HHS committed up to $4.9 million to the effort through the Advanced Research Projects Agency for Health, the department announced Nov. 12. The Cost Plus-led teams will build the regulatory, clinical, chemical and engineering foundation for a single-molecule ibogaine hydrochloride product. Separately, Beond will generate clinical… Originally published in Becker’s Hospital Review. Read More

Share this post

Integrated Psychiatric Consultants

Office Hours:
Mon-Fri, 9 a.m. - 5 p.m. CT

Reach out today.

Integrated Psychiatric Consultants (IPC) is committed to protecting and respecting your privacy. Our team will use the information collected here solely to serve your needs and notify you about relevant services. To consent, please check the box above and submit this form.

Please note, this consent applies to all forms of communications, including SMS. If you have provided a mobile phone number above, you agree to receiving SMS messages from IPC. You may unsubscribe at any time. Message frequency varies. Messaging and data rates may apply. Reply STOP to cancel. For more information, please review our Privacy Policy.